Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws.
Sunday, August 16
Trending
- NATIONAL DIGITAL HEALTH INFORMATION SYSTEM SUCCESSFULLY DEPLOYED AT JNF GENERAL HOSPITAL
- SCHOOL BUS FLEET STRENGTHENED AHEAD OF NEW ACADEMIC YEAR
- Saint Kitts and Nevis Champions Human Rights, Youth Leadership and Peace at 20th International Human Rights Summit
- Prime Minister Drew Urges Taiwan Scholarship Recipients To Return Home Ready to Contribute To National Development
- EDUCATION MINISTER WELCOMES LARGEST-EVER TAIWAN SCHOLARSHIP COHORT FOR SAINT KITTS AND NEVIS
- St. Kitts and Nevis Pursues New Medical Scholarship Pathway Through Taiwan Partnership
- Government Targets Improved Patient Outcomes Through Major Strengthening of Nursing Workforce
- 37 NATIONALS AWARDED TAIWAN SCHOLARSHIPS AS GOVERNMENT SIGNALS PLANS TO DOUBLE OPPORTUNITIES IN 2027

